Robert S Nishime, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location · Robert S Nishime MD Inc · 2 clinicians in this group
Looking this up.
Hospitals listed: 557754 · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nishime’s office at (408) 293-5864 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A62708 · Current
Licensed to practise in California · since 1997 · expires 2027-05-31 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$62,660
Medicare paid this office $62,660 for 196 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 130 | $28,713 | $100 |
| Long return visit (40+ min) | 72 | $14,962 | $139 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,508 | $157 |
| Short return visit (20+ min) | 39 | $3,504 | $75 |
| New patient visit (45+ min) | 13 | $1,531 | $118 |
See all 8 services
| Return visit (30+ min) | 130 | $28,713 | $100 |
| Long return visit (40+ min) | 72 | $14,962 | $139 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $5,508 | $157 |
| Short return visit (20+ min) | 39 | $3,504 | $75 |
| New patient visit (45+ min) | 13 | $1,531 | $118 |
| Influenza vaccine split virus, preservative free | 17 | $1,458 | $77 |
| Administration of influenza virus vaccine | 18 | $781 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $340 | $18 |
Procedures Medicare counted
| Removal of skin lesions | 26 | More than 67% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 17 | More than 70% of doctors who do this |
Who their Medicare patients are
196 Original Medicare patients in 2024. Average age 76 · Women 50% · Also on Medicaid 6% · Health risk score 0.78. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 70% · Diabetes 27% · Coronary heart disease 18% · Chronic kidney disease 13% · Atrial fibrillation 13% · Heart failure 11% · Cancer 10% · Depression 8% · Dementia 7% · Stroke 6%.
The office billed $122,327, Medicare allowed $92,426 and paid $62,660; for 785 services of 43 kinds; $2,172 of it was for drugs given in the office and $60,488 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 196 | 785 | 76 | 0.78 | $122,327 | $62,660 |
| 2023 | 190 | 865 | 77 | 0.76 | $121,354 | $62,772 |
| 2022 | 202 | 859 | 76 | 0.75 | $126,241 | $69,310 |
| 2021 | 195 | 807 | 75 | 0.76 | $112,988 | $63,818 |
| 2020 | 153 | 556 | 76 | 0.82 | $84,167 | $40,964 |
| 2019 | 235 | 800 | 76 | 0.90 | $146,457 | $58,304 |
| 2018 | 211 | 806 | 76 | 0.85 | $136,322 | $54,730 |
| 2017 | 150 | 427 | 76 | 0.89 | $62,315 | $26,883 |
| 2016 | 134 | 379 | 76 | 0.93 | $65,367 | $26,619 |
| 2015 | 181 | 781 | 76 | 0.97 | $129,505 | $62,341 |
| 2014 | 198 | 934 | 75 | 0.83 | $153,300 | $72,847 |
| 2013 | 187 | 782 | 75 | 1.02 | $116,753 | $54,118 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 118 | $24,389 | $100 |
| Long return visit (40+ min) | 87 | $18,808 | $146 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $5,145 | $156 |
| Short return visit (20+ min) | 42 | $3,666 | $63 |
| Influenza vaccine split virus, preservative free | 14 | $1,137 | $71 |
| Adm sarscv2 bvl 50mcg/.5ml a | 15 | $739 | $49 |
| Administration of influenza virus vaccine | 13 | $547 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $361 | $17 |
2022: 10 services
| Long return visit (40+ min) | 76 | $22,920 | $158 |
| Return visit (30+ min) | 108 | $18,204 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $6,804 | $158 |
| Short return visit (20+ min) | 58 | $4,741 | $59 |
| Influenza vaccine split virus, preservative free | 31 | $2,121 | $68 |
| Adm sarscv2 bvl 50mcg/.5ml a | 37 | $1,827 | $49 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 28 | $1,381 | $49 |
| Administration of influenza virus vaccine | 32 | $1,192 | $37 |
| New patient visit (45+ min) | 11 | $793 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $191 | $9 |
2021: 9 services
| Return visit (30+ min) | 100 | $19,117 | $109 |
| Long return visit (40+ min) | 64 | $16,828 | $163 |
| Short return visit (20+ min) | 71 | $8,232 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | $7,324 | $163 |
| Influenza vaccine split virus, preservative free | 32 | $2,149 | $65 |
| New patient visit (45+ min) | 11 | $1,300 | $118 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 22 | $993 | $45 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $768 | $20 |
| Administration of influenza virus vaccine | 34 | $763 | $22 |
2020: 8 services
| Return visit (30+ min) | 78 | $13,288 | $97 |
| Long return visit (40+ min) | 37 | $7,483 | $136 |
| Short return visit (20+ min) | 61 | $6,385 | $57 |
| Influenza vaccine split virus, preservative free | 47 | $2,860 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,439 | $143 |
| New patient visit (45+ min) | 13 | $1,781 | $137 |
| Administration of influenza virus vaccine | 48 | $1,004 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $727 | $23 |
2019: 10 services
| Return visit (30+ min) | 120 | $17,456 | $86 |
| Short return visit (20+ min) | 115 | $10,399 | $56 |
| Long return visit (40+ min) | 56 | $8,625 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $4,744 | $140 |
| Influenza vaccine split virus, preservative free | 31 | $1,644 | $53 |
| New patient visit (45+ min) | 13 | $1,428 | $110 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,063 | $56 |
| Administration of influenza virus vaccine | 31 | $636 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $249 | $15 |
| Urinalysis, manual test | 13 | $48 | $3 |
2018: 9 services
| Return visit (30+ min) | 111 | $17,007 | $83 |
| Long return visit (40+ min) | 56 | $10,060 | $118 |
| Short return visit (20+ min) | 96 | $7,535 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,399 | $136 |
| Influenza vaccine split virus, preservative free | 33 | $1,674 | $51 |
| New patient visit (30+ min) | 16 | $1,107 | $69 |
| Aspiration and/or injection of fluid from large joint | 14 | $1,005 | $44 |
| Administration of influenza virus vaccine | 38 | $1,003 | $26 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | $136 | None |
2017: 6 services
| Return visit (30+ min) | 69 | $8,733 | $95 |
| Long return visit (40+ min) | 25 | $4,419 | $123 |
| Short return visit (20+ min) | 53 | $4,214 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,166 | $134 |
| Administration of influenza virus vaccine | 39 | $1,259 | $32 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 39 | $682 | $17 |
2016: 3 services
| Return visit (30+ min) | 84 | $11,714 | $77 |
| Long return visit (40+ min) | 28 | $3,749 | $107 |
| Short return visit (20+ min) | 58 | $3,442 | $42 |
2015: 8 services
| Return visit (30+ min) | 127 | $20,979 | $88 |
| Long return visit (40+ min) | 72 | $16,738 | $127 |
| Short return visit (20+ min) | 81 | $6,972 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,341 | $137 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $3,006 | $200 |
| Administration of influenza virus vaccine | 39 | $1,206 | $31 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 38 | $672 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $196 | $15 |
2014: 14 services
| Return visit (30+ min) | 131 | $24,460 | $89 |
| Long return visit (40+ min) | 79 | $20,765 | $126 |
| Short return visit (20+ min) | 77 | $6,422 | $58 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 26 | $5,156 | $198 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,639 | $135 |
| New patient visit (45+ min) | 19 | $2,584 | $136 |
| New patient visit (30+ min) | 17 | $1,254 | $74 |
| Administration of influenza virus vaccine | 39 | $1,152 | $30 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 42 | $580 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $307 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $176 | $14 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 13 | $62 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 16 | $1 | None |
| Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 12 | $1 | None |
2013: 9 services
| Return visit (30+ min) | 129 | $22,138 | $89 |
| Long return visit (40+ min) | 57 | $9,171 | $118 |
| Short return visit (20+ min) | 91 | $8,164 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,524 | $133 |
| New patient visit (30+ min) | 14 | $1,087 | $78 |
| Administration of influenza virus vaccine | 33 | $970 | $29 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 33 | $401 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $345 | $19 |
| Evaluation of use of breathing device | 12 | $316 | $18 |
Drugs they prescribed that Part D paid
$181,611
Pharmacies billed $181,611 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (118 of 2,967) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 14% of their opioid prescriptions.
2,687 generic and 263 brand-name prescriptions · $181,611 in drug cost · 104 antibiotic prescriptions to 64 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $21,031 | $1,052 |
| Ozempic | 14 | $13,249 | $946 |
| Mounjaro | 12 | $12,829 | $1,069 |
| Tradjenta | 15 | $10,768 | $718 |
| Jardiance | 12 | $6,556 | $546 |
See all 67 drugs
| Eliquis | 20 | $21,031 | $1,052 |
| Ozempic | 14 | $13,249 | $946 |
| Mounjaro | 12 | $12,829 | $1,069 |
| Tradjenta | 15 | $10,768 | $718 |
| Jardiance | 12 | $6,556 | $546 |
| Basaglar Kwikpen U-100 | 13 | $3,806 | $293 |
| Hydrocodone-Acetaminophen | 57 | $2,645 | $46 |
| Atorvastatin | 209 | $1,602 | $8 |
| Metoprolol | 103 | $1,495 | $15 |
| Paxlovid | 32 | $1,429 | $45 |
| Wixela Inhub | 17 | $1,293 | $76 |
| Albuterol Sulfate Hfa | 80 | $1,222 | $15 |
| Oxycodone-Acetaminophen | 19 | $1,062 | $56 |
| Losartan | 128 | $1,045 | $8 |
| Tamsulosin | 80 | $1,004 | $13 |
| Gabapentin | 23 | $846 | $37 |
| Rosuvastatin | 52 | $812 | $16 |
| Lisinopril | 130 | $790 | $6 |
| Levothyroxine | 54 | $780 | $14 |
| Metformin | 120 | $779 | $6 |
| Amlodipine Besylate | 128 | $764 | $6 |
| Fenofibrate | 21 | $630 | $30 |
| Celecoxib | 60 | $609 | $10 |
| Losartan-Hydrochlorothiazide | 37 | $603 | $16 |
| Morphine Sulfate Er | 13 | $579 | $45 |
| Fluticasone-Salmeterol | 11 | $509 | $46 |
| Pantoprazole | 24 | $502 | $21 |
| Simvastatin | 75 | $500 | $7 |
| Allopurinol | 22 | $458 | $21 |
| Etodolac | 21 | $430 | $20 |
| Econazole Nitrate | 24 | $416 | $17 |
| Oxybutynin Chloride Er | 15 | $401 | $27 |
| Omeprazole | 40 | $363 | $9 |
| Diphenoxylate-Atropine | 12 | $359 | $30 |
| Valacyclovir | 11 | $338 | $31 |
| Clopidogrel | 19 | $335 | $18 |
| Diclofenac | 14 | $301 | $22 |
| Metoprolol | 26 | $290 | $11 |
| Famotidine | 39 | $282 | $7 |
| Montelukast | 22 | $279 | $13 |
| Escitalopram | 19 | $278 | $15 |
| Sertraline | 21 | $246 | $12 |
| Valsartan-Hydrochlorothiazide | 23 | $240 | $10 |
| Lisinopril-Hydrochlorothiazide | 18 | $217 | $12 |
| Trazodone | 28 | $164 | $6 |
| Sildenafil Citrate | 18 | $154 | $9 |
| Clonazepam | 17 | $133 | $8 |
| Finasteride | 14 | $130 | $9 |
| Cefdinir | 15 | $130 | $9 |
| Hydrochlorothiazide | 49 | $127 | $3 |
| Zolpidem | 19 | $125 | $7 |
| Terazosin | 11 | $110 | $10 |
| Pioglitazone | 11 | $107 | $10 |
| Tramadol | 21 | $99 | $5 |
| Amoxicillin-Clavulanate Potass | 15 | $82 | $5 |
| Alendronate | 16 | $76 | $5 |
| Valsartan | 12 | $75 | $6 |
| Metformin Hcl Er | 17 | $66 | $4 |
| Hydrocortisone | 11 | $63 | $6 |
| Azithromycin | 23 | $60 | $3 |
| Meloxicam | 40 | $51 | $1 |
| Furosemide | 12 | $44 | $4 |
| Fluoxetine | 12 | $43 | $4 |
| Lorazepam | 22 | $40 | $2 |
| Atenolol | 18 | $29 | $2 |
| Amoxicillin | 21 | $29 | $1 |
| Fluticasone Propionate | 16 | $25 | $2 |
Year by year
| 2024 | 2,967 | 288 | 4% (118) | 9% | $181,611 |
| 2023 | 2,285 | 237 | 3% (70) | 8% | $153,704 |
| 2022 | 1,937 | 213 | 2% (46) | 7% | $123,757 |
| 2021 | 1,665 | 191 | 3% (42) | 5% | $84,395 |
| 2020 | 1,474 | 165 | 4% (61) | 7% | $78,729 |
| 2019 | 1,329 | 166 | 4% (59) | None | $52,184 |
| 2018 | 1,220 | 163 | 4% (51) | None | $58,040 |
| 2017 | 1,236 | 166 | 5% (57) | None | $60,226 |
| 2016 | 1,272 | 159 | 5% (67) | None | $110,770 |
| 2015 | 1,116 | 153 | 8% (87) | None | $70,740 |
| 2014 | 998 | 128 | 8% (80) | None | $84,979 |
| 2013 | 857 | 114 | 8% (66) | 21% | $59,867 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Eliquis | 11 | $16,940 | $1,540 |
| Januvia | 11 | $12,390 | $1,126 |
| Advair Diskus | 14 | $6,340 | $453 |
| Basaglar Kwikpen U-100 | 12 | $4,030 | $336 |
| Atorvastatin | 175 | $1,937 | $11 |
| Losartan | 123 | $1,877 | $15 |
| Metoprolol | 94 | $1,830 | $19 |
| Hydrocodone-Acetaminophen | 28 | $1,778 | $63 |
| Tamsulosin | 67 | $1,264 | $19 |
| Rosuvastatin | 41 | $1,248 | $30 |
| Etodolac | 24 | $1,185 | $49 |
| Fenofibrate | 21 | $1,141 | $54 |
| Amlodipine Besylate | 124 | $1,132 | $9 |
| Metformin | 99 | $998 | $10 |
| Albuterol Sulfate Hfa | 36 | $995 | $28 |
| Trazodone | 24 | $943 | $39 |
| Losartan-Hydrochlorothiazide | 31 | $846 | $27 |
| Simvastatin | 69 | $750 | $11 |
| Lisinopril | 77 | $703 | $9 |
| Levothyroxine | 39 | $627 | $16 |
| Verapamil Er | 12 | $603 | $50 |
| Quetiapine | 16 | $600 | $38 |
| Oxybutynin Chloride Er | 11 | $514 | $47 |
| Morphine Sulfate Er | 12 | $501 | $42 |
| Celecoxib | 20 | $450 | $23 |
| Escitalopram | 15 | $417 | $28 |
| Econazole Nitrate | 16 | $414 | $26 |
| Cefdinir | 11 | $332 | $30 |
| Finasteride | 19 | $298 | $16 |
| Metoprolol | 23 | $295 | $13 |
| Pantoprazole | 20 | $284 | $14 |
| Famotidine | 20 | $283 | $14 |
| Allopurinol | 17 | $274 | $16 |
| Lovastatin | 22 | $272 | $12 |
| Cyclobenzaprine | 13 | $247 | $19 |
| Paxlovid (Eua) | 25 | $222 | $9 |
| Hydrochlorothiazide | 47 | $219 | $5 |
| Sildenafil Citrate | 15 | $215 | $14 |
| Mometasone Furoate | 15 | $203 | $14 |
| Clonazepam | 15 | $182 | $12 |
| Fluticasone Propionate | 18 | $181 | $10 |
| Valsartan-Hydrochlorothiazide | 17 | $179 | $11 |
| Lisinopril-Hydrochlorothiazide | 16 | $144 | $9 |
| Triamterene-Hydrochlorothiazid | 13 | $143 | $11 |
| Meloxicam | 40 | $136 | $3 |
| Amoxicillin-Clavulanate Potass | 11 | $126 | $11 |
| Azithromycin | 30 | $123 | $4 |
| Olmesartan Medoxomil | 11 | $121 | $11 |
| Zolpidem | 13 | $113 | $9 |
| Fluoxetine | 15 | $112 | $7 |
| Tramadol | 14 | $102 | $7 |
| Omeprazole | 21 | $67 | $3 |
| Amoxicillin | 17 | $64 | $4 |
| Atenolol | 13 | $63 | $5 |
2022: 43 drugs
| Januvia | 11 | $12,852 | $1,168 |
| Flovent Hfa | 12 | $4,424 | $369 |
| Metoprolol | 85 | $1,861 | $22 |
| Hydrocodone-Acetaminophen | 18 | $1,421 | $79 |
| Losartan | 125 | $1,421 | $11 |
| Rosuvastatin | 38 | $1,404 | $37 |
| Atorvastatin | 132 | $1,208 | $9 |
| Tamsulosin | 55 | $1,090 | $20 |
| Fenofibrate | 16 | $1,017 | $64 |
| Albuterol Sulfate Hfa | 24 | $864 | $36 |
| Amlodipine Besylate | 114 | $750 | $7 |
| Metformin | 78 | $732 | $9 |
| Pravastatin | 24 | $610 | $25 |
| Lisinopril | 76 | $552 | $7 |
| Levothyroxine | 39 | $502 | $13 |
| Quetiapine | 14 | $444 | $32 |
| Verapamil Er | 11 | $436 | $40 |
| Simvastatin | 64 | $424 | $7 |
| Lisinopril-Hydrochlorothiazide | 14 | $375 | $27 |
| Fenofibrate | 22 | $336 | $15 |
| Trazodone | 25 | $328 | $13 |
| Lovastatin | 24 | $312 | $13 |
| Omeprazole | 27 | $309 | $11 |
| Famotidine | 12 | $306 | $26 |
| Allopurinol | 15 | $275 | $18 |
| Alendronate | 13 | $262 | $20 |
| Gabapentin | 13 | $248 | $19 |
| Econazole Nitrate | 12 | $227 | $19 |
| Mometasone Furoate | 13 | $217 | $17 |
| Paxlovid (Eua) | 20 | $211 | $11 |
| Hydrochlorothiazide | 36 | $203 | $6 |
| Triamterene-Hydrochlorothiazid | 14 | $187 | $13 |
| Cefdinir | 12 | $186 | $16 |
| Pantoprazole | 15 | $181 | $12 |
| Losartan-Hydrochlorothiazide | 12 | $165 | $14 |
| Zolpidem | 18 | $156 | $9 |
| Meloxicam | 45 | $149 | $3 |
| Sildenafil Citrate | 13 | $105 | $8 |
| Atenolol | 18 | $104 | $6 |
| Metoprolol | 13 | $97 | $7 |
| Azithromycin | 18 | $67 | $4 |
| Fluoxetine | 11 | $63 | $6 |
| Ciprofloxacin | 12 | $39 | $3 |
2021: 34 drugs
| Losartan | 118 | $1,868 | $16 |
| Metoprolol | 62 | $1,402 | $23 |
| Rosuvastatin | 34 | $1,296 | $38 |
| Atorvastatin | 96 | $1,117 | $12 |
| Fenofibrate | 18 | $1,012 | $56 |
| Amlodipine Besylate | 112 | $994 | $9 |
| Tamsulosin | 53 | $891 | $17 |
| Hydrocodone-Acetaminophen | 25 | $880 | $35 |
| Lisinopril | 63 | $826 | $13 |
| Fluoxetine | 19 | $732 | $39 |
| Mometasone Furoate | 17 | $599 | $35 |
| Metformin | 71 | $578 | $8 |
| Etodolac | 12 | $551 | $46 |
| Pravastatin | 24 | $524 | $22 |
| Levothyroxine | 31 | $511 | $16 |
| Simvastatin | 65 | $473 | $7 |
| Fenofibrate | 20 | $377 | $19 |
| Pantoprazole | 15 | $352 | $23 |
| Lovastatin | 22 | $352 | $16 |
| Omeprazole | 17 | $306 | $18 |
| Allopurinol | 17 | $303 | $18 |
| Zolpidem | 25 | $286 | $11 |
| Cefdinir | 12 | $234 | $19 |
| Hydrochlorothiazide | 44 | $196 | $4 |
| Triamterene-Hydrochlorothiazid | 14 | $181 | $13 |
| Metoprolol | 13 | $154 | $12 |
| Gabapentin | 11 | $141 | $13 |
| Metformin Hcl Er | 11 | $139 | $13 |
| Econazole Nitrate | 12 | $124 | $10 |
| Meloxicam | 28 | $109 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $105 | $9 |
| Carvedilol | 12 | $96 | $8 |
| Atenolol | 19 | $90 | $5 |
| Ciprofloxacin | 12 | $39 | $3 |
2020: 35 drugs
| Hydrocodone-Acetaminophen | 38 | $1,714 | $45 |
| Fenofibrate | 16 | $1,620 | $101 |
| Metoprolol | 45 | $1,335 | $30 |
| Pravastatin | 34 | $1,204 | $35 |
| Atorvastatin | 77 | $1,157 | $15 |
| Losartan | 65 | $1,125 | $17 |
| Rosuvastatin | 15 | $954 | $64 |
| Albuterol Sulfate Hfa | 19 | $902 | $47 |
| Tamsulosin | 57 | $877 | $15 |
| Lisinopril | 63 | $794 | $13 |
| Mometasone Furoate | 19 | $694 | $37 |
| Diphenoxylate-Atropine | 13 | $675 | $52 |
| Amlodipine Besylate | 94 | $675 | $7 |
| Simvastatin | 60 | $572 | $10 |
| Levothyroxine | 21 | $545 | $26 |
| Latanoprost | 20 | $431 | $22 |
| Metformin | 53 | $363 | $7 |
| Fluoxetine | 20 | $352 | $18 |
| Allopurinol | 17 | $293 | $17 |
| Omeprazole | 15 | $266 | $18 |
| Lovastatin | 17 | $253 | $15 |
| Hydrochlorothiazide | 37 | $215 | $6 |
| Clonazepam | 14 | $212 | $15 |
| Metformin Hcl Er | 11 | $168 | $15 |
| Trazodone | 12 | $158 | $13 |
| Atenolol | 17 | $155 | $9 |
| Zolpidem | 20 | $127 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $124 | $11 |
| Azithromycin | 18 | $108 | $6 |
| Acetaminophen-Codeine | 15 | $99 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $94 | $9 |
| Benazepril | 11 | $93 | $8 |
| Meloxicam | 40 | $87 | $2 |
| Amoxicillin | 11 | $68 | $6 |
| Lorazepam | 16 | $51 | $3 |
2019: 35 drugs
| Hydrocodone-Acetaminophen | 44 | $2,277 | $52 |
| Ventolin Hfa | 26 | $1,952 | $75 |
| Metoprolol | 38 | $1,590 | $42 |
| Fenofibrate | 18 | $1,513 | $84 |
| Atorvastatin | 86 | $1,379 | $16 |
| Pravastatin | 34 | $1,067 | $31 |
| Tamsulosin | 46 | $908 | $20 |
| Rosuvastatin | 23 | $836 | $36 |
| Amlodipine Besylate | 85 | $816 | $10 |
| Losartan | 52 | $704 | $14 |
| Lisinopril | 63 | $568 | $9 |
| Simvastatin | 43 | $514 | $12 |
| Levothyroxine | 18 | $495 | $27 |
| Propranolol | 11 | $411 | $37 |
| Fluoxetine | 15 | $379 | $25 |
| Gabapentin | 12 | $318 | $27 |
| Pioglitazone | 11 | $307 | $28 |
| Bupropion Xl | 12 | $305 | $25 |
| Finasteride | 11 | $302 | $27 |
| Econazole Nitrate | 11 | $295 | $27 |
| Metformin | 41 | $287 | $7 |
| Allopurinol | 14 | $269 | $19 |
| Metoprolol | 16 | $238 | $15 |
| Lovastatin | 16 | $226 | $14 |
| Hydrochlorothiazide | 30 | $218 | $7 |
| Clopidogrel | 12 | $203 | $17 |
| Sertraline | 26 | $189 | $7 |
| Metformin Hcl Er | 18 | $177 | $10 |
| Azithromycin | 25 | $157 | $6 |
| Clonazepam | 18 | $152 | $8 |
| Donepezil | 11 | $138 | $13 |
| Zolpidem | 14 | $107 | $8 |
| Trazodone | 11 | $94 | $9 |
| Lisinopril-Hydrochlorothiazide | 13 | $85 | $7 |
| Meloxicam | 20 | $83 | $4 |
2018: 29 drugs
| Hydrocodone-Acetaminophen | 38 | $2,516 | $66 |
| Metoprolol | 41 | $1,722 | $42 |
| Atorvastatin | 75 | $1,323 | $18 |
| Fenofibrate | 12 | $1,103 | $92 |
| Mometasone Furoate | 16 | $1,041 | $65 |
| Pravastatin | 25 | $1,007 | $40 |
| Proair Hfa | 13 | $790 | $61 |
| Amlodipine Besylate | 85 | $770 | $9 |
| Tamsulosin | 30 | $764 | $25 |
| Lisinopril | 59 | $530 | $9 |
| Losartan | 45 | $514 | $11 |
| Rosuvastatin | 16 | $505 | $32 |
| Levothyroxine | 19 | $494 | $26 |
| Allopurinol | 18 | $466 | $26 |
| Metformin | 56 | $463 | $8 |
| Simvastatin | 37 | $405 | $11 |
| Latanoprost | 26 | $362 | $14 |
| Pioglitazone | 11 | $341 | $31 |
| Finasteride | 16 | $284 | $18 |
| Escitalopram | 14 | $276 | $20 |
| Trazodone | 12 | $216 | $18 |
| Metformin Hcl Er | 23 | $212 | $9 |
| Lovastatin | 12 | $181 | $15 |
| Atenolol | 13 | $162 | $12 |
| Donepezil | 12 | $153 | $13 |
| Azithromycin | 27 | $151 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $122 | $11 |
| Meloxicam | 19 | $117 | $6 |
| Hydrochlorothiazide | 21 | $106 | $5 |
2017: 31 drugs
| Mometasone Furoate | 15 | $3,761 | $251 |
| Hydrocodone-Acetaminophen | 45 | $1,661 | $37 |
| Atorvastatin | 76 | $1,593 | $21 |
| Pravastatin | 41 | $1,064 | $26 |
| Metoprolol | 22 | $896 | $41 |
| Levothyroxine | 30 | $843 | $28 |
| Tamsulosin | 26 | $730 | $28 |
| Amlodipine Besylate | 87 | $727 | $8 |
| Pioglitazone | 14 | $510 | $36 |
| Simvastatin | 45 | $431 | $10 |
| Etodolac | 12 | $417 | $35 |
| Allopurinol | 15 | $401 | $27 |
| Lisinopril | 42 | $392 | $9 |
| Clopidogrel | 12 | $374 | $31 |
| Losartan | 42 | $366 | $9 |
| Escitalopram | 24 | $361 | $15 |
| Latanoprost | 23 | $291 | $13 |
| Metformin | 35 | $271 | $8 |
| Metformin Hcl Er | 19 | $244 | $13 |
| Lovastatin | 17 | $205 | $12 |
| Hydrochlorothiazide | 31 | $161 | $5 |
| Azithromycin | 25 | $147 | $6 |
| Omeprazole | 14 | $141 | $10 |
| Enalapril Maleate | 11 | $135 | $12 |
| Meloxicam | 34 | $118 | $3 |
| Carvedilol | 14 | $112 | $8 |
| Atenolol | 16 | $105 | $7 |
| Lisinopril-Hydrochlorothiazide | 19 | $100 | $5 |
| Zolpidem | 13 | $97 | $7 |
| Lorazepam | 12 | $78 | $7 |
| Clonazepam | 12 | $48 | $4 |
2016: 29 drugs
| Hydrocodone-Acetaminophen | 43 | $2,067 | $48 |
| Mometasone Furoate | 14 | $1,821 | $130 |
| Atorvastatin | 63 | $1,504 | $24 |
| Levothyroxine | 36 | $1,205 | $33 |
| Metoprolol | 21 | $943 | $45 |
| Fluoxetine | 11 | $903 | $82 |
| Tamsulosin | 28 | $843 | $30 |
| Pravastatin | 19 | $834 | $44 |
| Etodolac | 17 | $784 | $46 |
| Amlodipine Besylate | 66 | $537 | $8 |
| Simvastatin | 48 | $464 | $10 |
| Lisinopril | 51 | $461 | $9 |
| Clopidogrel | 12 | $354 | $30 |
| Losartan | 41 | $298 | $7 |
| Metformin | 25 | $234 | $9 |
| Rizatriptan | 13 | $234 | $18 |
| Pioglitazone | 19 | $213 | $11 |
| Atenolol | 24 | $195 | $8 |
| Hydrochlorothiazide | 26 | $194 | $7 |
| Lovastatin | 15 | $192 | $13 |
| Azithromycin | 26 | $175 | $7 |
| Fluticasone Propionate | 13 | $174 | $13 |
| Losartan-Hydrochlorothiazide | 16 | $173 | $11 |
| Escitalopram | 17 | $166 | $10 |
| Zolpidem | 18 | $114 | $6 |
| Ciprofloxacin | 11 | $77 | $7 |
| Carvedilol | 11 | $75 | $7 |
| Meloxicam | 24 | $66 | $3 |
| Alendronate | 14 | $63 | $5 |
2015: 32 drugs
| Nasonex | 13 | $2,754 | $212 |
| Hydrocodone-Acetaminophen | 53 | $2,270 | $43 |
| Atorvastatin | 53 | $1,172 | $22 |
| Pravastatin | 23 | $979 | $43 |
| Metoprolol | 21 | $945 | $45 |
| Levothyroxine | 28 | $828 | $30 |
| Etodolac | 23 | $785 | $34 |
| Valsartan-Hydrochlorothiazide | 11 | $689 | $63 |
| Proair Hfa | 11 | $567 | $52 |
| Lisinopril | 49 | $525 | $11 |
| Tamsulosin | 15 | $479 | $32 |
| Zolpidem | 14 | $428 | $31 |
| Simvastatin | 32 | $329 | $10 |
| Amlodipine Besylate | 42 | $322 | $8 |
| Metformin | 33 | $310 | $9 |
| Clopidogrel | 14 | $279 | $20 |
| Gabapentin | 12 | $262 | $22 |
| Lorazepam | 34 | $226 | $7 |
| Lovastatin | 13 | $223 | $17 |
| Atenolol | 24 | $189 | $8 |
| Losartan-Hydrochlorothiazide | 18 | $177 | $10 |
| Azithromycin | 24 | $177 | $7 |
| Acetaminophen-Codeine | 14 | $173 | $12 |
| Hydrochlorothiazide | 25 | $144 | $6 |
| Meloxicam | 27 | $141 | $5 |
| Fluticasone Propionate | 12 | $132 | $11 |
| Triamterene-Hydrochlorothiazid | 13 | $123 | $9 |
| Losartan | 13 | $114 | $9 |
| Ciprofloxacin | 16 | $103 | $6 |
| Alendronate | 16 | $81 | $5 |
| Carvedilol | 11 | $63 | $6 |
| Metoprolol | 12 | $57 | $5 |
2014: 31 drugs
| Oxycontin | 11 | $5,401 | $491 |
| Spiriva | 11 | $3,214 | $292 |
| Atorvastatin | 52 | $1,842 | $35 |
| Hydrocodone-Acetaminophen | 49 | $1,221 | $25 |
| Etodolac | 25 | $1,102 | $44 |
| Proair Hfa | 14 | $1,095 | $78 |
| Metoprolol | 13 | $1,000 | $77 |
| Pravastatin | 21 | $734 | $35 |
| Clopidogrel | 13 | $626 | $48 |
| Amlodipine Besylate | 48 | $565 | $12 |
| Levothyroxine | 18 | $487 | $27 |
| Simvastatin | 30 | $416 | $14 |
| Gabapentin | 14 | $362 | $26 |
| Tamsulosin | 15 | $345 | $23 |
| Tramadol | 12 | $301 | $25 |
| Lisinopril | 25 | $290 | $12 |
| Alendronate | 21 | $226 | $11 |
| Metformin | 24 | $218 | $9 |
| Atenolol | 23 | $208 | $9 |
| Finasteride | 13 | $182 | $14 |
| Azithromycin | 21 | $167 | $8 |
| Losartan | 13 | $157 | $12 |
| Hydrochlorothiazide | 17 | $145 | $9 |
| Cephalexin | 11 | $111 | $10 |
| Zolpidem | 11 | $105 | $10 |
| Ciprofloxacin | 16 | $99 | $6 |
| Lorazepam | 19 | $97 | $5 |
| Citalopram Hbr | 11 | $95 | $9 |
| Pantoprazole | 11 | $92 | $8 |
| Enalapril Maleate | 12 | $81 | $7 |
| Meloxicam | 13 | $56 | $4 |
2013: 22 drugs
| Spiriva | 11 | $3,013 | $274 |
| Crestor | 13 | $2,279 | $175 |
| Atorvastatin | 34 | $1,533 | $45 |
| Diovan | 12 | $1,389 | $116 |
| Metoprolol | 12 | $1,334 | $111 |
| Proair Hfa | 12 | $1,074 | $89 |
| Hydrocodone-Acetaminophen | 39 | $691 | $18 |
| Losartan | 27 | $483 | $18 |
| Amlodipine Besylate | 31 | $470 | $15 |
| Simvastatin | 22 | $392 | $18 |
| Pravastatin | 14 | $308 | $22 |
| Levothyroxine | 25 | $302 | $12 |
| Lisinopril | 26 | $296 | $11 |
| Metformin | 21 | $285 | $14 |
| Etodolac | 11 | $259 | $24 |
| Azithromycin | 21 | $217 | $10 |
| Atenolol | 21 | $206 | $10 |
| Hydrochlorothiazide | 15 | $170 | $11 |
| Zolpidem | 19 | $107 | $6 |
| Lorazepam | 14 | $87 | $6 |
| Enalapril Maleate | 12 | $84 | $7 |
| Ciprofloxacin | 12 | $82 | $7 |
Professional record
- NPI
- 1225087984
- Licence
- CA A62708California A62708: Current · expires 2027-05-31
- Trained
- Rush Medical College of Rush University, 1994
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A627080
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X)
- Mailing address
- 900 Lafayette St Ste 105, Santa Clara, CA, 95050
- NPI first listed
- 2006-05-09
- NPI last updated
- 2019-07-26
This is when the NPI record was last certified, not a medical board exam.